Bifidobacterium longum BB536
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Bifidobacterium longum BB536, covering 2017-11-06 to 2019-01-24. Get the full timeline:
Most recent: Clinical Trial Update: A Novel Formulation of Bifidobacterium Longum BB536 and Lactobacillus Rhamnosus HN001 With Vitamin B6 on IBS Patients [Phase 3]